引導式測驗 · 中等 等級

攝護腺癌 MRI 之 AI 應用測驗

測試 AI 對前列腺 MRI、PI-RADS 背景、研究普遍性、臨床審查和以患者為中心的追蹤的支持。

問題 1 的 8

What can AI contribute to prostate MRI interpretation?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. What can AI contribute to prostate MRI interpretation?
    • Confirm cancer without pathology or clinical context
    • Choose a biopsy treatment plan automatically
    • Replace all MRI sequences with one image score
    • Localize candidate lesions or support risk assessment for clinician review
  2. What does PI-RADS provide in prostate MRI?
    • A guarantee that a detected lesion is malignant
    • A laboratory quality-control requirement
    • A structured framework radiologists use to describe and assess findings
    • A genetic variant classification standard
  3. Why is prospective validation useful after a promising MRI AI study?
    • It guarantees improved patient outcomes
    • It tests whether performance transfers to real clinical workflows and populations
    • It proves the model will work on every scanner
    • It removes the need for a reference standard
  4. Which evidence should be used to evaluate prostate MRI AI?
    • Pathology or well-defined follow-up, with relevant sensitivity and specificity measures
    • Only the model’s training loss
    • The number of highlighted pixels
    • The clinician’s preferred image viewer
  5. Why can a retrospective enriched test set overstate performance?
    • It has too many MRI sequences to interpret
    • Pathology cannot be used as a reference
    • It automatically represents every clinic
    • Its patient mix may differ from the population and prevalence where the tool will be used
  6. How should a patient interpret an AI-highlighted prostate lesion?
    • As a treatment recommendation from the model
    • As a finding for radiologist and clinician assessment, not a diagnosis
    • As proof that cancer is present
    • As proof that biopsy is unnecessary
  7. What information should accompany a prostate MRI AI audit?
    • Scanner and sequence protocol, software version, reader interaction, and follow-up outcomes
    • Only the radiologist’s initials
    • The model’s color palette
    • The patient’s unrelated billing history
  8. Which decision belongs in shared clinical decision-making?
    • The scan score overriding patient preference
    • A software update setting the biopsy threshold without review
    • Whether AI findings, PSA, history, and other evidence support biopsy or follow-up
    • The model alone deciding treatment